EB - Madrigal announces US launch of NASH/MASH drug Rezdiffra
2024-04-09 10:03:48 ET
More on Madrigal Pharmaceuticals
- Madrigal: Accelerated Rezdiffra Approval Puts It In The NASH Lead
- Madrigal Wins The 'MASH Dash' And A Chance To Shape The Market Before GLP-1 Challenge
- Madrigal Pharmaceuticals: Perceived Threat From Eli Lilly Is Overblown
- Madrigal Pharmaceuticals commences underwritten public offering
- NASH drug market expected to surpass $48B by 2035